BridgeBio Pharma (BBIO) Inventory Average (2025 - 2026)

BridgeBio Pharma (BBIO) posted Inventory Average of $29.9 million for Q1 2026, up 16.48% sequentially from $25.6 million in Q4 2025.

Analysis

BridgeBio Pharma (BBIO) Inventory Average (2025 - 2026) Analysis & Trends

BridgeBio Pharma has reported Inventory Average for 2 years, with the latest figure at $29.9 million in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	213.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	707.10 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	90.57 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	137.65 Mn
10	BridgeBio Pharma	14.65 Bn	13.93 Bn	228.63 Mn	42.91 Mn

Historic Data

Download Data